Skip to content

Abstract 4980: Interplay Between Body Mass Index and Patient-Reported Health Status in Early-Stage Hypertrophic Cardiomyopathy

Nov 2026 · Circulation · 0 citations

Abstract

Background: Symptoms and functional impairments have historically represented the primary targets of hypertrophic cardiomyopathy (HCM) management. Obesity has been shown to be associated with worse symptoms and clinical outcomes in HCM, but the extent to which obesity influences patient-reported health status across the clinical spectrum of HCM is uncertain. Methods: In this secondary analysis of the international phase 2 VANISH (Valsartan for Attenuating Disease Evolution in Early Sarcomeric HCM) trial, we first examined the associational strength of baseline covariates (including body mass index [BMI]) with baseline Pediatric Quality of Life Inventory (PedsQL) composite scores. Second, the association between BMI and individual PedsQL domains was examined. Third, we evaluated the interplay between baseline BMI, and 2-year changes in BMI, with PedsQL trajectories. Results: Among 178 (100%) VANISH participants (mean age, 23±10 years; 39% female; 97% White; mean BMI, 25±6 kg/m 2 ), the mean PedsQL composite score at baseline was 84±11, signifying good health-related quality of life. Baseline BMI was the strongest predictor of baseline PedsQL composite scores, followed by age, left ventricular end-diastolic volume index, and genotype (thick vs. thin filament variants) ( Figure 1 ). Higher baseline BMI was significantly and linearly associated with lower PedsQL composite scores ( P <0.001), driven by impairments in the physical ( P <0.001), social ( P =0.005), and school/work domains ( P =0.006) ( Figure 2 ). While baseline BMI were not strongly associated with 2-year PedsQL trajectories, participants with greater increases in BMI appeared to experience greater declines in physical functioning scores ( P trend =0.049) ( Figure 3 ). Baseline BMI did not appear to modify the effect of valsartan on PedsQL scores ( P interaction =0.66). Conclusions: In this analysis, BMI was a dominant determinant of health status impairments and associated with worse physical and psychosocial function, even in early-stage HCM. While further studies in later HCM stages are needed, these findings support efforts beyond the sarcomere to address quality of life impairments in HCM.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.